Incidence and impact of atrial fibrillation in heart failure patients: real-world data in a large community

被引:4
|
作者
Diaz, Javier [1 ]
Martinez, Fernando [1 ,2 ]
Miguel Calderon, Jose [1 ]
Fernandez, Antonio [1 ]
Sauri, Inmaculada [1 ]
Uso, Ruth [1 ]
Luis Trillo, Jose [1 ]
Redon, Josep [1 ,3 ]
Jose Forner, Maria [1 ,2 ]
机构
[1] Univ Valencia, INCLIVA Res Inst, Cardiovasc & Renal Res Grp, Valencia, Spain
[2] Internal Med Hosp Clin Valencia, Valencia, Spain
[3] CIBERObn Carlos III Inst, Madrid, Spain
来源
ESC HEART FAILURE | 2022年 / 9卷 / 06期
关键词
Heart failure; Atrial fibrillation; Hospitalization; Renal function; Stroke; All-cause mortality; CHRONIC KIDNEY-DISEASE; RISK; ASSOCIATIONS; PREDICTORS;
D O I
10.1002/ehf2.14124
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aims The objective of the present study is to assess the bidirectional association between heart failure (HF) and atrial fibrillation (AF) using real-world data. Methods and results From an electronic health recording with a population of 3 799 885 adult subjects, those with prevalent or incident HF were selected and followed throughout a study period of 5 years. Prevalence and incidence of AF, and their impact in the risk for acute HF hospitalization, worsening renal function, ischaemic and haemorrhagic stroke, and all-cause mortality were identified. We analysed all incident and prevalent patients with HF and AF, 128 086 patients (S1), and subsequently analysed a subset of patients with incident HF and AF, 57 354 patients (S2). We analysed all incident and prevalent patients with HF and AF, 128 086 patients (S1), and subsequently a subset of patients with incident HF and AF, 57 354 patients (S2). The prevalence of AF was 59 906 (46.7%) of the HF patients, while incidence in the 52 was 231/1000 patients/year. In both cohorts, S1 and S2, AF significantly increases the risk of acute heart failure hospitalization [incidence 79.1/1000 and 97.5/1000 patients/year; HR 1.53 (1.48-1.59 95% CI) and HR 1.32 (1.24-1.41 95% CI), respectively], risk of decreased renal function (eGFR reduced by >20%) [66.2/1000 and 94.0/1000 patients/year; HR 1.13 (1.09-1.18 95% CI) and HR 1.22 (1.14-1.31 95% CI), respectively] and all-cause mortality [203/1000 and 294/1000 patients/year; HR 1.62 (1.58-1.65 95% CI) and HR 1.65 (1.59-1.70 95% CI), respectively]. The number of episodes of hospitalization for acute heart failure was also significantly higher in the AF patients (27 623 vs. 10 036, P < 0.001). However, the risk for ischaemic stroke was reduced in the AF subjects [HR 0.66 (0.63-0.74 95% Cl)), probably due to the anticoagulant treatment. Conclusions AF is associated with an increment in the risk of episodes of acute heart failure as well as decline of renal function and increment of all-cause mortality.
引用
收藏
页码:4230 / 4239
页数:10
相关论文
共 50 条
  • [1] IMPACT OF ATRIAL FIBRILLATION ON RENAL FUNCTION IN HEART FAILURE PATIENTS USING REAL WORLD DATA
    Diaz, Jvier
    Calderon, Jose Miguel
    Martinez, Fernando
    Sauri, Inmaculada
    Fernandez, Antonio
    Trillo, Jose Luis
    Uso, Ruth
    Redon, Josep
    JOURNAL OF HYPERTENSION, 2022, 40 (SUPPL) : E76 - E76
  • [2] Reduction of mortality by catheter ablation in real-world atrial fibrillation patients with heart failure
    Pil-Sung Yang
    Daehoon Kim
    Jung-Hoon Sung
    Eunsun Jang
    Hee Tae Yu
    Tae-Hoon Kim
    Jae-Sun Uhm
    Jong-Youn Kim
    Hui-Nam Pak
    Moon-Hyoung Lee
    Boyoung Joung
    Scientific Reports, 11
  • [3] Reduction of mortality by catheter ablation in real-world atrial fibrillation patients with heart failure
    Yang, Pil-Sung
    Kim, Daehoon
    Sung, Jung-Hoon
    Jang, Eunsun
    Yu, Hee Tae
    Kim, Tae-Hoon
    Uhm, Jae-Sun
    Kim, Jong-Youn
    Pak, Hui-Nam
    Lee, Moon-Hyoung
    Joung, Boyoung
    SCIENTIFIC REPORTS, 2021, 11 (01)
  • [4] Incidence of atrial fibrillation detected by an insertable cardiac monitor in a large real-world cohort of heart failure patients with reduced and preserved ejection fraction
    Khan, M. Shahzeb
    Kahwash, R.
    Zile, M. R.
    Sarkar, S.
    Van Dorn, B.
    Gerritse, B.
    Butler, J.
    EUROPEAN HEART JOURNAL, 2024, 45
  • [5] Incidence of atrial fibrillation detected by an insertable cardiac monitor in a large real-world cohort of heart failure patients with reduced and preserved ejection fraction
    Shahzeb Khan, M.
    Kahwash, R.
    Zile, M. R.
    Sarkar, S.
    Van Dorn, B.
    Gerritse, B.
    Butler, J.
    EUROPEAN HEART JOURNAL, 2024, 45
  • [6] Rivaroxaban and apixaban in patients with atrial fibrillation; a real-world data
    Aslan, Onur
    Yildirim, Sinan
    TURKISH JOURNAL OF MEDICAL SCIENCES, 2022, 52 (04) : 948 - 957
  • [7] The burden of atrial fibrillation and heart failure in hospitalized patients: A real-world survey in a nationwide snapshot
    Iliodromitis, Konstantinos
    Tzeis, Stylianos
    Xintarakou, Anastasia
    Pyrgakis, Vlasios
    Zari, Ioannis
    Patsilinakos, Sotirios
    Draganigos, Antonios
    Triposkiadis, Filippos
    Hahalis, George
    Karanasios, Athanasios
    Goudevenos, Ioannis
    Michalis, Lampros
    Karvounis, Charalampos
    Parthenakis, Fraggiskos
    Kanakakis, Ioannis
    Tousoulis, Dimitrios
    Iliodromitis, Efstathios
    Vardas, Panos
    HELLENIC JOURNAL OF CARDIOLOGY, 2023, 74 : 18 - 23
  • [8] Prolonged PR interval and incidence of atrial fibrillation, heart failure admissions, and mortality in patients with implanted cardiac devices: A real-world
    Yarmohammadi, Hirad
    Wan, Elaine Y.
    Biviano, Angelo
    Garan, Hasan
    Koehler, Jodi L.
    Stadler, Robert W.
    HEART RHYTHM O2, 2023, 4 (03): : 171 - 179
  • [9] Identification and Mapping Real-World Data Sources for Heart Failure, Acute Coronary Syndrome, and Atrial Fibrillation
    Studer, Rachel
    Sartini, Claudio
    Suzart-Woischnik, Kiliana
    Agrawal, Rumjhum
    Natani, Harshul
    Gill, Simrat K.
    Wirta, Sara Bruce
    Asselbergs, Folkert W.
    Dobson, Richard
    Denaxas, Spiros
    Kotecha, Dipak
    CARDIOLOGY, 2022, 147 (01) : 98 - 106
  • [10] Population pharmacokinetic analysis and dosage recommendations for digoxin in Japanese patients with atrial fibrillation and heart failure using real-world data
    Toshinori Hirai
    Hidefumi Kasai
    Miyoko Naganuma
    Nobuhisa Hagiwara
    Tsuyoshi Shiga
    BMC Pharmacology and Toxicology, 23